Jointown Pharmaceutical Group Co., Ltd (SHA:600998)
China flag China · Delayed Price · Currency is CNY
5.13
-0.04 (-0.77%)
Oct 29, 2026, 1:15 PM CST

SHA:600998 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
22,03018,81417,39016,94917,17614,702
Short-Term Investments
15.11124.0315.1195.0190289.15
Trading Asset Securities
898.2674.16972.3490.03319.723,597
Cash & Short-Term Investments
22,94319,01218,37817,13417,58618,588
Cash Growth
26.39%3.45%7.26%-2.57%-5.39%24.51%
Accounts Receivable
40,36432,67531,62729,37530,51128,224
Other Receivables
4,6023,7893,8813,1592,3953,029
Receivables
44,96636,49035,54432,58232,90731,305
Inventory
29,37730,25422,85120,11417,21315,517
Prepaid Expenses
-82.4817.6416.8-22.94
Other Current Assets
5,8499,4547,4355,7797,9525,737
Total Current Assets
103,13695,29284,22575,62575,65871,170
Property, Plant & Equipment
8,9599,3108,9788,9638,6488,521
Long-Term Investments
5,2454,5514,0923,5523,2982,413
Goodwill
1,2161,348799.37759.68813.38581.43
Other Intangible Assets
2,5442,5252,1121,8951,8632,195
Long-Term Deferred Tax Assets
937.98820.33658.83476.42434.7288.42
Long-Term Deferred Charges
346.01364.19224.97283.7261.01196.38
Other Long-Term Assets
2,0942,1971,3061,2331,336570.62
Total Assets
124,477116,407102,39692,78992,31285,936

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
58,16854,07546,51040,10139,29534,158
Accrued Expenses
621.09942.39810.71786.92780.82631.62
Short-Term Debt
14,66311,4659,93610,12211,49313,055
Current Portion of Long-Term Debt
790.24809.981,3892,040413.421,767
Current Portion of Leases
-289.47170.8278.6579.2187.16
Current Income Taxes Payable
437.11331.38545.81267.28306.73178.7
Current Unearned Revenue
2,4322,8481,6911,7032,502966.06
Other Current Liabilities
5,4175,5895,3504,9674,8144,551
Total Current Liabilities
82,52976,35066,40360,06659,68455,394
Long-Term Debt
1,8951,6431,0182,3362,9802,379
Long-Term Leases
714.65853.33698.94170.99195.64180.29
Long-Term Unearned Revenue
295.11271.61233.6244.45306.49343.39
Long-Term Deferred Tax Liabilities
385.79377.11346.58378.47459.6566.11
Other Long-Term Liabilities
25.7844.24102.73116.25--
Total Liabilities
85,84579,54068,80363,31263,62658,863

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
5,0425,0425,0423,9091,8741,874
Additional Paid-In Capital
5,2115,1925,2076,3538,2058,056
Retained Earnings
17,34816,75315,58514,05412,95011,546
Treasury Stock
-345.89-461.77-632.46-581.86-774.24-614.82
Comprehensive Income & Other
234.46257.3269.21248.37402.59564.73
Total Common Equity
27,49026,78325,47123,98322,65721,426
Minority Interest
9,3708,3136,3505,4944,0463,664
Shareholders' Equity
38,63236,86833,59329,47728,68527,073
Total Liabilities & Equity
124,477116,407102,39692,78992,31285,936

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
18,06315,06113,21214,74715,16217,469
Net Cash (Debt)
4,8803,9525,1652,3872,4241,119
Net Cash Growth
123.21%-23.50%116.38%-1.52%116.56%-
Net Cash Per Share
0.950.771.030.470.460.22
Filing Date Shares Outstanding
4,8534,9864,9865,0264,9124,963
Total Common Shares Outstanding
4,8534,9864,9865,0264,9454,963
Working Capital
20,60718,94217,82215,55915,97315,775
Book Value Per Share
5.665.375.114.774.544.28
Tangible Book Value
23,73122,91022,56021,32819,98118,649
Tangible Book Value Per Share
4.894.594.524.244.003.72
Buildings
-8,7298,4548,2357,5156,536
Machinery
-3,9893,3693,2192,9652,779
Construction In Progress
-688.25383.92634.92865.371,523